A Study of an Oral Ifetroban for People with Symptomatic Aspirin Exacerbated Respiratory Disease (AERD)

What we are studying

The purpose of this study is to find out if the medication ifetroban will improve the symptoms and quality-of-life of patients with symptomatic Aspirin Exacerbated Respiratory Disease (AERD). AERD is a respiratory (breathing) condition in which a person develops breathing problems because they are extremely sensitive to the drug Aspirin (a common pain reliver) and similar drugs.

Who is Eligible

  • All Genders
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosed with Symptomatic Aspirin Exacerbated Respiratory Disease (AERD)
  • Further Criteria Will Be Discussed with Study Team

What is involved

  • Informed Consent Review
  • Review of Medical History
  • Physical Examinations
  • Phone Calls and/or Emails
  • Study Visits and Consultations
  • Surveys/Questionnaires
  • Laboratory and Imaging Tests
  • Use of Study Treatments or Placebo
  • After Study Follow-Up Activities

Compensation

The study team will talk with potential participants about the compensation provided in this study.

Contact Information

Study Coordinator
Bob Hmieleski
Email
bhmieles@wakehealth.edu
Phone
(336) 713-8550
Principal Investigator
Wendy Moore

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.